• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Endotoxemia as a trigger of thrombosis in cirrhosis.

作者信息

Violi Francesco, Lip Gregory Y H, Cangemi Roberto

机构信息

Department of Internal Medicine and Medical Specialties; Sapienza University, Rome, Italy

University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK.

出版信息

Haematologica. 2016 Apr;101(4):e162-3. doi: 10.3324/haematol.2015.139972.

DOI:10.3324/haematol.2015.139972
PMID:27033239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5004387/
Abstract
摘要

相似文献

1
Endotoxemia as a trigger of thrombosis in cirrhosis.内毒素血症作为肝硬化中血栓形成的触发因素。
Haematologica. 2016 Apr;101(4):e162-3. doi: 10.3324/haematol.2015.139972.
2
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.肝硬化中血管性血友病因子与凝血因子VIII的门体循环梯度：对门静脉血栓形成的影响
Clin Transl Gastroenterol. 2020 Feb;11(2):e00123. doi: 10.14309/ctg.0000000000000123.
3
MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis.伴有和不伴有门静脉血栓形成的肝硬化中的亚甲基四氢叶酸还原酶（MTHFR）C677T突变
Liver Int. 2006 Mar;26(2):269-70. doi: 10.1111/j.1478-3231.2005.01215.x.
4
Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis.肠道菌群失调、内毒素血症与凝血激活：肝硬化门静脉血栓形成的危险三联征
Blood Rev. 2023 Jan;57:100998. doi: 10.1016/j.blre.2022.100998. Epub 2022 Aug 12.
5
Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.肝硬化中低度内毒素血症引起的全身凝血激活：内皮促凝激活的潜在作用。
Ital J Gastroenterol Hepatol. 1997 Oct;29(5):434-40.
6
Elevated factor VIII levels and the risk of thrombosis.因子VIII水平升高与血栓形成风险
Arterioscler Thromb Vasc Biol. 2001 May;21(5):731-8. doi: 10.1161/01.atv.21.5.731.
7
Anticoagulation for portal vein thrombosis in cirrhosis.肝硬化门静脉血栓形成的抗凝治疗
Am J Med. 2010 Sep;123(9):e19-20; author reply e21. doi: 10.1016/j.amjmed.2010.03.019.
8
The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.肝硬化门脉高压大鼠内毒素血症与肝内源性大麻素的关系。
J Hepatol. 2011 Jun;54(6):1145-53. doi: 10.1016/j.jhep.2010.09.026. Epub 2010 Nov 12.
9
Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis.D-二聚体和蛋白S在肝硬化患者门静脉血栓形成诊断中的价值。
J Int Med Res. 2013 Jun;41(3):664-72. doi: 10.1177/0300060513483413. Epub 2013 May 1.
10
Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat?肝硬化患者的非恶性部分门静脉血栓形成：治疗还是不治疗？
Radiology. 2013 Mar;266(3):994-5. doi: 10.1148/radiol.12122259.

引用本文的文献

1
Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?肝硬化患者的门静脉血栓形成：出了什么问题？
Int J Gen Med. 2023 Aug 28;16:3889-3906. doi: 10.2147/IJGM.S413438. eCollection 2023.
2
Gut microbiome metabolites as key actors in atherosclerosis co-depression disease.肠道微生物群代谢产物在动脉粥样硬化合并抑郁症中起关键作用。
Front Microbiol. 2022 Nov 10;13:988643. doi: 10.3389/fmicb.2022.988643. eCollection 2022.
3
Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.门静脉直径增加可预测肝硬化患者门静脉血栓形成。
Ann Transl Med. 2021 Feb;9(4):289. doi: 10.21037/atm-20-4912.
4
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.非肿瘤性门静脉血栓形成：肝硬化的一个具有挑战性的后果。
J Clin Transl Hepatol. 2020 Dec 28;8(4):432-444. doi: 10.14218/JCTH.2020.00067. Epub 2020 Nov 11.
5
Serum lipopolysaccharides predict advanced liver disease in the general population.血清脂多糖可预测普通人群中的晚期肝病。
JHEP Rep. 2019 Oct 23;1(5):345-352. doi: 10.1016/j.jhepr.2019.09.001. eCollection 2019 Nov.
6
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.肠道通透性在肝损伤发病机制中的作用：从非酒精性脂肪性肝病到肝移植。
World J Gastroenterol. 2019 Sep 7;25(33):4814-4834. doi: 10.3748/wjg.v25.i33.4814.

本文引用的文献

1
Should the term coagulopathy in cirrhosis be abandoned?肝硬化中的凝血病这一术语是否应被摒弃？
JAMA Intern Med. 2015 May;175(5):862-3. doi: 10.1001/jamainternmed.2015.90.
2
Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.1,243 例肝硬化患者门静脉血栓形成的病因和后果：一项纵向研究的结果。
Hepatology. 2015 Feb;61(2):660-7. doi: 10.1002/hep.27546. Epub 2015 Jan 5.
3
Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.肝硬化中的凝血激活和纤维蛋白溶解亢进：对出血和血栓形成的影响。
Semin Thromb Hemost. 2013 Jun;39(4):426-33. doi: 10.1055/s-0033-1334144. Epub 2013 Mar 13.
4
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.血管性血友病因子作为肝硬化患者门静脉高压、失代偿和死亡的新的无创预测因子。
Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27.
5
The coagulopathy of chronic liver disease.慢性肝病的凝血功能障碍
N Engl J Med. 2011 Jul 14;365(2):147-56. doi: 10.1056/NEJMra1011170.
6
The role of intestinal endotoxin in liver injury: a long and evolving history.肠道内毒素在肝损伤中的作用：一段漫长而演变的历史。
Hepatology. 2010 Nov;52(5):1829-35. doi: 10.1002/hep.23917.
7
Factor VIII expression in liver disease.肝脏疾病中的凝血因子VIII表达。
Thromb Haemost. 2004 Feb;91(2):267-75. doi: 10.1160/TH03-05-0310.
8
Enhanced expression of monocyte tissue factor in patients with liver cirrhosis.肝硬化患者单核细胞组织因子表达增强。
Gut. 1998 Sep;43(3):428-32. doi: 10.1136/gut.43.3.428.
9
Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.
Hepatology. 1988 Mar-Apr;8(2):232-6. doi: 10.1002/hep.1840080207.
10
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.内毒素在体外可增强人血管内皮细胞的组织因子表达并抑制血栓调节蛋白的表达。
J Clin Invest. 1987 Jan;79(1):124-30. doi: 10.1172/JCI112772.